Allergy

Article	Citations
In this Issue: Graphical Abstracts	687
Issue Information	343
Issue Information	294
Issue Information	256
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	196
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	189
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	171
Type 2 memory B cells: The repository of allergic memory?	158
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	149
TOP10‐SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions	145
	143
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	129
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	122
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	121
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle	112
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	107
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	105
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern	101
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	101
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	99
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	96
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	94
Legends of allergology and immunology: Per Brandtzaeg – Pillar of mucosal immunology	93
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	86
Experimental rhinovirus infection induces an antiviral response in circulating B cells which is dysregulated in patients with asthma	85

Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial	83
Health effects of exposure to chlorination by‐products in swimming pools	82
Large scale regulatory T cells screening	82
In memoriam: Lawrence M. Lichtenstein (1934–2022)	81
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	80
MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin–proteasomal degradation in allergic rhinitis pathogenesis	80
Allergenic components of the mRNA‐1273 vaccine for COVID‐19: Possible involvement of polyethylene glycol and IgG‐mediated complement activation	77
Persistence of infectious SARS‐CoV‐2 particles for up to 37 days in patients with mild COVID‐19	74
Preclinical Development of GR2002, a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects	73
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	73
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	73
Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants	72
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures	72
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	71
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP and Radioallergosorbent Test	67
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	66
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies	64
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	63
Immunoglobulin E response in health and disease beyond allergic disorders	62
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3+ Tregs	62
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	61
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	61
Development and validation of the food allergy severity score	61
Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	60
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	60
Issue Information ‐ TOC	59
Issue Information	59
In this Issue: Graphical Abstracts	59
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	59
Issue Information	59
Neuron−macrophage interaction in the healing process of the skin	58
Allergoid‐mannan conjugates imprint tolerogenic features in human macrophages	58
What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders	58
	57
Severe and refractory anaphylaxis in pediatric intensive care unit	57
Type 2 IgG Memory B Cells as Precursors of IgE Plasma Cells	56
Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function	54
Oral abstracts (OAS)	53
Issue Information	53
Allergic Reactivity and Memory Occur Independently of Sequential Switching Through IgG1	53
Anatomical Distribution and Quantification of IgE Secretion in Mouse Models of House Dust Mite Allergy	52
Reply to “Aspergillus fumigatus and personalized medicine: Toward a clinically reliable algorithm”	52
Discrepancies in Beta‐Lactam Antibiotics Cross‐Reactivity: Implications for Clinical Practice	52
Sputum transcriptome analysis of co‐regulated genes related to arachidonic acid metabolism in N‐ERD	52
Beta2‐adrenergic agonists can enhance intense performance and muscle strength in healthy individuals	51
Effects of allergen immunotherapy in the MASK‐air study: a proof‐of‐concept analysis	51
The Molecular Allergology User's Guide version 2.0 is freely available!	51
Recurrence of anaphylaxis: A systematic review of observational studies	50
NK cells and lipoxin A4 promote resolution of eosinophilic inflammation after nasal allergen challenge	50
Early expansion of allergen‐responsive LAP+ B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy	49

TFEB signaling attenuates NLRP3‐driven inflammatory responses in severe asthma	49
Immunotherapeutic effects of specific and nonspecific mRNA‐lipid nanoparticles in a mouse model of HDM‐induced airway inflammation	47
Gastrointestinal Barrier Disruption in Post‐COVID Syndrome Fatigue Patients	47
Tissue‐specific contribution of mucosal‐associated invariant T cells to allergic airway inflammation	47
Efficacy and safety of topical Streptococcus postbiotic emollient in adolescents and adults with mild‐to‐moderate atopic dermatitis: A randomized, double‐blind, vehicle‐controlled trial	47
EAACI guidelines on environmental science in allergic diseases and asthma – Leveraging artificial intelligence and machine learning to develop a causality model in exposomics	46
Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications	46
Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization	46
Management of anaphylaxis due to COVID‐19 vaccines in the elderly	45
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study	45
Non‐immediate hypersensitivity reactions to iomeprol: Diagnostic value of skin tests and cross‐reactivity with other iodinated contrast media	44
Evidence of epithelial remodelling but not epithelial–mesenchymal transition by transcriptome profiling in vernal keratoconjunctivitis	44
Network analysis reveals age‐ and virus‐specific circuits in nasal epithelial cells of extremely premature infants	44
CT‐P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double‐Blind, Randomized, Active‐Controlled, Phase 3 Study	44
Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice	44
Mast cell activation is associated with post‐acute COVID‐19 syndrome	44
Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging	43
Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up	43
In this issue: Graphical abstract	42
Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades	42
Issue Information	42
Reply to correspondence: “The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark”	42
Oncostatin‐M Is Produced by Human Eosinophils and Expression Is Increased in Uncontrolled Severe Asthma	42
Impact of a drug allergy education course for non‐specialists: Findings from ADAPT—A randomized crossover trial	41
IL‐13: An essential cDC2s partner to maintain skin homeostasis	41
Issue Information	41
SEB‐induced IL‐13 production in CLA+ memory T cells defines Th2 high and Th2 low responders in atopic dermatitis	41
Intralymphatic Administration of Naked mRNA Induces Allergen‐Specific IgG, Promotes Th1 Responses and Reduces Anaphylactic Potential	41
Efficacy and Safety Profile of Animal Dander Immunotherapy: A Multicentre UK Study	40
Harnessing mass spectrometric methods for exquisite allergen product characterization	40
Allergen‐Specific B Cell Responses Following Desensitisation and Natural Tolerance to Cow's Milk Allergy	40
Salivary Metabolomic Signatures in Pediatric Eosinophilic Esophagitis	40
Abstract	39
Deciphering the Connection Between Atopic Dermatitis and Cardiovascular Diseases: Analysis of Clinical Associations and Cardiometabolic Proteins	39
Exiting the Anthropocene: Achieving personal and planetary health in the 21st century	39
Development of the Cold Urticaria Activity Score	39
Combining avidin with CD63 improves basophil activation test accuracy in classifying peanut allergy	38
COVID‐19 vaccines tolerated in patients with paclitaxel and docetaxel allergy	38
Serological testing for SARS‐CoV‐2 antibodies in clinical practice: A comparative diagnostic accuracy study	37
Successful rapid desensitization in a glioma patient with procarbazine‐mediated anaphylaxis	36
Legends of allergy and immunology: Otto Scheiner	36
SARS‐CoV‐2 infection in severe asthma is associated with worsening of COVID‐19 through respiratory NLRP3 inflammasome activation	36
Glatiramer acetate induces mast cell degranulation via MRGPRX2, implications for local and systemic adverse reactions	36
Patient‐reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life	36
Effect of venom immunotherapy and sting challenge on health‐related quality of life measured by venom‐allergy quality of life questionnaire (VQLQ) in Jack jumper ant allergic patients	36
IL‐13 signature in severe adult asthmatics with airway neutrophilia: A new endotype to treat!	35
A vaccine targeting human IL‐4 and IL‐13 protects against asthma in humanized mice	34
Quantitative analysis of urinary cytokines in food‐allergic and healthy individuals	34
Sweet syndrome induced by SARS‐CoV‐2 Pfizer‐BioNTech mRNA vaccine	34
Genetic variants in the TLR‐related pathway and smoking exposure alter the upper airway microbiota in adult asthmatic patients	34
Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria	33
Food Allergy Genetics and Epigenetics: A Review of Genome‐Wide Association Studies	33
Indirect case‐matched comparison of anti‐IL4Rα versus anti‐IL5Rα on airway hyperresponsiveness	33
Incidence of healthcare utilization for allergic and respiratory infectious diseases in children with asthma before and during the COVID‐19 pandemic	33
Targeting interleukin‐5 with benralizumab: A novel treatment for drug rash with eosinophilia and systemic symptoms	33
Biological treatment in allergic disease	33
Cost‐effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma	32
Sex hormones and asthma: The role of estrogen in asthma development and severity	32
Emollients for prevention of atopic dermatitis: 5‐year findings from the BEEP randomized trial	32
Cashew oral immunotherapy for desensitizing cashew‐pistachio allergy (NUT CRACKER study)	32
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry	32
	31
Issue Information	31
Recombinant Hypoallergenic Cat Allergy Vaccines	31
Issue Information	31
	31
Allergen‐specific B cell responses in oral immunotherapy‐induced desensitization, remission, and natural outgrowth in cow's milk allergy	31
Optimal dose of adrenaline auto‐injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study	31
Author Index	31
Particulate Matter 2.5 Aggravates Airway Inflammation by Neutrophil‐Mediated Inflammasome Activation	31
Efficacy of eHealth monitoring in pediatric asthma	31
Different mechanisms distinguishing childhood allergic diseases including allergic march	30
Can polyamine metabolism in T helper cell lineage commitment be a new target in allergy research?	30
Type 1/17 CD103+CD4+ nasal‐resident memory T cells in non‐eosinophilic chronic rhinosinusitis with nasal polyps	30
Effects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction	30
Safety of COVID‐19 vaccine challenge in patients with immediate adverse reactions to prior doses: A multi‐centre cohort study	30
Interferon‐γ‐inducible protein 10 augments atopic dermatitis via amplifying Th2 immune response	30
Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis	30
Is there a direct link between skin barrier dysfunction and asthma?	30
Differentiation of bronchial epithelial spheroids in the presence of IL‐13 recapitulates characteristic features of asthmatic airway epithelia	30

The impact of dupilumab treatment on SARS‐CoV‐2 T cell responses in atopic dermatitis patients	30
Gut microbiota and Lactobacillus species maintain the small intestine stem cell niche and ameliorate the severity of necrotizing enterocolitis	30
Epidemiological variations in global burden of atopic dermatitis: An analysis of trends from 1990 to 2019	30
Poultry exposure and environmental protection against asthma in rural children	30
Long‐term follow‐up of neutrophil activation after severe‐to‐critical SARS‐CoV‐2 infection: A longitudinal study	29
On a Rainy Day, Placebo Is the Ideal Treatment for Your Hay Fever	29
Legends of Allergy and Immunology: Gianni Marone	29
The stimulation of TH2 cells results in increased IL‐5 and IL‐13 production via the H4 receptor	29
CLA+ memory T cells in atopic dermatitis	29
Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen‐specific IgE production	29
Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database	29
Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?	29
Mapping the way to strengthening epithelial barriers: Neuronal circuits in mucus regulation	29
Author Index	28
Two‐Year Data of Tapered Dupilumab Shows High Effectiveness in CRSwNP With NSAID‐Exacerbated Respiratory Disease	28
The Bronchodilator and Anti‐Inflammatory Effect of Long‐Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper	28
Fecal microbiota transplantation against moderate‐to‐severe atopic dermatitis: A randomized, double‐blind controlled explorer trial	28
Advances and highlights in asthma in 2021	28
Flow‐based basophil activation test in immediate drug hypersensitivity. An EAACI task force position paper	28
Suppressed IgG4 class switching in dupilumab‐ and TNF inhibitor‐treated patients after mRNA vaccination	28
IL‐13, periostin and dipeptidyl‐peptidase‐4 reveal endotype‐phenotype associations in atopic dermatitis	28
Thrombin cleaves IL‐33 and modulates IL‐33‐activated allergic lung inflammation	28
Climate change: A call to action for the United Nations	28
IgE glycosylation is essential for the function of omalizumab	28
In this issue: Graphical abstract	27
Effect‐modifying impact of age on sex‐based differences during oral immunotherapy	27
Obituary: Professor Marcus Maurer, Berlin, Germany	26
Infantile colic is associated with development of later constipation and atopic disorders	26
Issue Information	26
Correction to “Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge”	26
Issue Information	26
Human Milk Microbiome Is Associated With Allergic Diseases in Early Childhood	26
In this Issue: Graphical Abstracts	26
Corrigendum to “Immune Regulation by Intralymphatic Immunotherapy With Modular Allergen Translocation MAT Vaccine”	25
Allergenic potency of various foods of mammalian origin in patients with α‐Gal syndrome	25
Exhaled Nitric Oxide and Sputum Eosinophils Are Complementary Tools for Diagnosing Occupational Asthma	25
Global burden of vaccine‐associated angioedema and their related vaccines, 1967–2023: Findings from the global pharmacovigilance database	25
Tissue levels of Alternaria allergen Alt a 1 reflect recurrence of refractory airway diseases	25
Allergen‐Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years	25
Anaphylaxis Induced by Goat's and Sheep's Milk: An Allergen That We Should Keep Under Surveillance	25
Incidence of adverse events prompting switching between biologics among adults with asthma: A retrospective cohort study	24
How type‐2 dendritic cells induce Th2 differentiation: Instruction, repression, or fostering T cell‐T cell communication?	24
Systematic review of the association between short‐chain fatty acids and allergic diseases	24
Long‐term changes in milk component immunoglobulins reflect milk oral immunotherapy outcomes in Finnish children	24
Reply to correspondence: Emollients in infancy to prevent atopic dermatitis: A systematic review and meta‐analysis	24
Metabolomics analysis of metabolic patterns in chronic rhinosinusitis with nasal polyps	24
Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study	24
Effect of indoor air pollution on atopic dermatitis in dogs	24
Physical exercise, immune response, and susceptibility to infections—current knowledge and growing research areas	24
Dietary fiber and fermented food consumption and its link to allergic responses	24
The association between allergic rhinitis and the risk of coronavirus disease 2019 (COVID‐19): A national survey in China	24
Helminths' therapeutic potential to treat intestinal barrier dysfunction	23
Different inflammatory features of asthma according to gut microbiome enterotype	23
Inverse association between Helicobacter pylori infection and atopic, skin, and autoimmune diseases: A nationwide population‐based study in South Korea	23
TH2 cytokines and Staphylococcus aureus cooperatively induce atopic dermatitis‐like transcriptomes	23
Identification of a functional DOCK8 gene polymorphism associated with atopic dermatitis	23
Eosinophilic allergic rhinitis is strongly associated with the CD45RBlo subset of CD161+ Th2 cells that secretes IL‐2, IL‐3, IL	23
Medical algorithm: Aspergillus fumigatus components in the diagnosis of allergic bronchopulmonary aspergillosis	23
Sesame eliciting and safe doses in a large sesame allergic population	23
Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL‐13 inhibition	22
COVID‐19 pandemic and allergen immunotherapy—an EAACI survey	22
Issue Information	22
Downregulation of Tight Junction Protein MAGI1 by Interferon‐γ Contributes to Barrier Dysfunction in Chronic Rhinosinusitis With Nasal Polyps	22
Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis	22
An algorithm for the management of radiocontrast media hypersensitivity, 2024 update	22
Allergen immunotherapy for asthma prevention: A systematic review and meta‐analysis of randomized and non‐randomized controlled studies	22
	22
Effect of anti‐IL‐5 biologics on weight and body mass index	22
Bulk T‐cell receptor sequencing confirms clonality in pediatric eosinophilic esophagitis and identifies a food‐specific repertoire	22
Identification of a defensin as novel allergen in celery root: Api g 7 as a missing link in the diagnosis of celery allergy?	22
Spatial transcriptomics combined with single‐cell RNA‐sequencing unravels the complex inflammatory cell network in atopic dermatitis	22
Issue Information ‐ TOC	21
Tetraspanin CD53 Promotes Inflammation but Restrains Mucus Production in a Mouse Model of Allergic Airway Inflammation	21
Vitamin D‐FUT2 interaction and risk of lower respiratory tract infections in childhood	21
Graphical abstracts and highlights	21
Legends of allergy and immunology: Alberto Mantovani, a visionary scientist unraveling the complexity of innate immunity in cancer and inflammation	21
	21
Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID‐exacerbated respiratory disease	21
Corrigendum: Role of yes‐associated protein in interleukin‐13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps	21
Issue information ‐ Cover and Editorial Board	21
Up‐dosing of reslizumab in severe asthmatics with persistent sputum eosinophilia: A feasibility study	21
The developing immune system in preterm born infants: From contributor to potential solution for respiratory tract infections and wheezing	21
Delta or Omicron BA.1/2‐neutralizing antibody levels and T‐cell reactivity after triple‐vaccination or infection	21
Issue Information	21
Issue Information ‐ TOC	21
Induction of immunosuppressive CD39 but not the trafficking C‐C chemokine receptor 4 on Treg during LAR in mite allergic asthma	20
Single low‐dose exposure to cow’s milk at diagnosis accelerates cow’s milk allergic infants’ progress on a milk ladder programme	20
Immune‐epithelial barrier interactions mediate intestinal adaptation to diverse diets	20
Asthma endotypes in elite athletes: A cross‐sectional study of European athletes participating in the Olympic Games	20
Selective eosinophil necroptosis contributes to airway inflammation and remodeling in asthma	20
Migration and allergic diseases: Findings from a population‐based study in adults in Amsterdam, the Netherlands	20
CMTM4 as a new partner for IL‐17 receptor: Adding a piece in the puzzle of IL17‐driven diseases	20
Effect of Haemophilus influenzae, Streptococcus pneumoniae and influenza vaccinations on infections, immune response and asthma control in preschool children with asthma	20
Anaphylaxis and desensitization differently activate and induce IL‐8 release by mast cells in a human peanut allergy in vitro model	20
Activation of succinate receptor 1 boosts human mast cell reactivity and allergic bronchoconstriction	20